MedPath

Clinical Evaluation of DAILIES TOTAL 1® Multifocal Compared to 1-Day Acuvue® Moist® Multifocal in a Japanese Population

Not Applicable
Completed
Conditions
Refractive Error
Presbyopia
Interventions
Device: Delefilcon A multifocal contact lenses
Device: Etafilcon A multifocal contact lenses
Registration Number
NCT03341923
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this clinical study is to evaluate DAILIES TOTAL1® Multifocal (DT1MF) contact lenses compared to 1-DAY ACUVUE® Moist® Multifocal (AMMF) contact lenses for investigator-graded lens centration in a Japanese population.

Detailed Description

Subjects will be randomly assigned to one of two sequences of investigational product wear ((DT1MF→AMMF, AMMF→DT1MF). Each product will be worn in both eyes for at least 11 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
151
Inclusion Criteria
  • Sign informed consent
  • Habitually wear multifocal soft/ silicone hydrogel contact lenses
  • Require a near spectacle ADD of +0.50 diopters (D) to +2.50D (inclusive)
  • Correctable to 20/30 Snellen or 0.2 logarithm minimum angle of resolution (logMAR) or better in each eye at distance
  • Willing to wear contact lenses and attend all study visits
Exclusion Criteria
  • Currently wearing DAILIES TOTAL 1® Multifocal or 1-DAY ACUVUE® Moist® Multifocal contact lenses
  • Any eye condition that would make contact lens wear unadvisable
  • Any use of medication that would make contact lens wear unadvisable
  • Prior refractive surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
AMMF, then DT1MFDelefilcon A multifocal contact lensesEtafilcon A multifocal contact lenses, followed by delefilcon A multifocal contact lenses. Each product worn in both eyes for 14 +/- 3 days.
DT1MF, then AMMFDelefilcon A multifocal contact lensesDelefilcon A multifocal contact lenses, followed by etafilcon A multifocal contact lenses. Each product worn in both eyes for 14 +/- 3 days.
DT1MF, then AMMFEtafilcon A multifocal contact lensesDelefilcon A multifocal contact lenses, followed by etafilcon A multifocal contact lenses. Each product worn in both eyes for 14 +/- 3 days.
AMMF, then DT1MFEtafilcon A multifocal contact lensesEtafilcon A multifocal contact lenses, followed by delefilcon A multifocal contact lenses. Each product worn in both eyes for 14 +/- 3 days.
Primary Outcome Measures
NameTimeMethod
Percentage of Subjects With Investigator-graded Lens Centration of "Optimal"Day 14, each product

Lens centration was assessed by slit-lamp microscopy and graded on a 5-point scale, where 0=Optimal/Centered and 4=Severe decentration (with corneal exposure). One target eye was randomly selected for analysis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alcon Investigative Site

🇯🇵

Taitō, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath